(Q36829236)

16 August 2017

1 reference

title

Treatment of cholestatic pruritus in children (English)

1 reference

16 August 2017

Jeffrey J Cies

1

1 reference

16 August 2017

John N Giamalis

series ordinal

2

1 reference

16 August 2017

publication date

1 June 2007

1 reference

American Journal of Health-System Pharmacy

16 August 2017

published in

1 reference

16 August 2017

volume

64

1 reference

16 August 2017

issue

11

1 reference

16 August 2017

page(s)

1157-1162

1 reference

The pruritus of cholestasis and the opioid system

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060453

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060453

Cholestasis in infancy. A review

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060453

Use of rifampin for severe pruritus in children with chronic cholestasis

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060453

Review article: pruritus in cholestatic and other liver diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060453

The pruritus of cholestasis: from bile acids to opiate agonists

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060453

The pruritus of cholestasis

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060453

The pruritus of cholestasis: potential pathogenic and therapeutic implications of opioids

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060453

Opioid antagonists in the treatment of pruritus from cholestatic liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060453

Induction of human cutaneous mast cell degranulation by opiates and endogenous opioid peptides: Evidence for opiate and nonopiate receptor participation

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060453

The British Society of Gastroenterology, 49th meeting. Sheffield, 14-16 September 1988. Abstracts

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060453

Opioid peptides and primary biliary cirrhosis

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060453

Serotonin and nociception

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060453

Serotonin receptor subtype antagonists in the medial ventral medulla inhibit mesencephalic opiate analgesia

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060453

Rifampin relieves pruritus in children with cholestatic liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060453

Effect of rifampicin in the treatment of pruritus in hepatic cholestasis

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060453

The antibiotic rifampicin is a nonsteroidal ligand and activator of the human glucocorticoid receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060453

A pilot, double-blind, controlled 1-year trial of prednisolone treatment in primary biliary cirrhosis: hepatic improvement but greater bone loss

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060453

The Effects of Phenobarbital on Bile Salts and Bilirubin in Patients with Intrahepatic and Extrahepatic Cholestasis

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060453

Effect of phenobarbital on hepatic transport and excretion of 131 I-rose bengal in children with cholestasis.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060453

Effect of ursodeoxycholic acid therapy on hepatic function in children with intrahepatic cholestatic liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060453

Ursodeoxycholate reduces hepatotoxicity of bile salts in primary human hepatocytes.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060453

Treatment of pruritus of obstructive jaundice with cholestyramine

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060453

Rational approach to pharmacologic reduction of cholesterol levels in children

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060453

Paroxetine in the treatment of severe non-dermatological pruritus: a randomized, controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060453

31 March 2020

Identifiers

DOI

10.2146/AJHP060453

1 reference

16 August 2017

1 reference